1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol has been researched along with iodoacetamide in 1 studies
Studies (1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol) | Trials (1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol) | Recent Studies (post-2010) (1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol) | Studies (iodoacetamide) | Trials (iodoacetamide) | Recent Studies (post-2010) (iodoacetamide) |
---|---|---|---|---|---|
23 | 0 | 10 | 1,502 | 0 | 130 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chander, A; Dodia, C; Fisher, AB | 1 |
1 other study(ies) available for 1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and iodoacetamide
Article | Year |
---|---|
Inhibition of lung calcium-independent phospholipase A2 by surfactant protein A.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Calcium; Cattle; Cells, Cultured; Glycerophosphates; Iodoacetamide; Lung; Male; Mercaptoethanol; Phospholipases A; Phospholipases A2; Proteolipids; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley | 1994 |